Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tick Borne Encephalitis (TBE)”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Large-scale testing (Phase 3)Study completedNCT02318069
What this trial is testing

New Study - Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Who this might be right for
Tick-borne Encephalitis
Sormland County Council, Sweden 250
Testing effectiveness (Phase 2)Study completedNCT01991067
What this trial is testing

Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients

Who this might be right for
Tick Borne Encephalitis
Medical University of Vienna 34
Large-scale testing (Phase 3)Study completedNCT01361776
What this trial is testing

Humoral Response to Tick-borne Encephalitis Vaccine in Elderly

Who this might be right for
Tick-borne Encephalitis
Sormland County Council, Sweden 200
Post-approval studies (Phase 4)UnknownNCT04573205
What this trial is testing

Primary TBE Vaccination for the Elderly

Who this might be right for
Tick-borne EncephalitisVaccine
Region Örebro County 90
Post-approval studies (Phase 4)UnknownNCT04017052
What this trial is testing

Application of a TBE-Vaccine in Obese Persons

Who this might be right for
Tick Borne Encephalitis
Medical University of Vienna 73
Post-approval studies (Phase 4)Study completedNCT00311493
What this trial is testing

Evaluation of Long-Term Immunogenicity in Subjects Boosted With a TBE Vaccine for Adults

Who this might be right for
Encephalitis, Tick-Borne
Novartis 179
Testing effectiveness (Phase 2)UnknownNCT00890422
What this trial is testing

Evaluation of Immunogenicity of Different Tick Borne Encephalitis (TBE) Fast Protective Traveler Schemes With Inactivated TBE Whole Virus Vaccine

Who this might be right for
Tick Borne Encephalitis
Elisabethinen Hospital 99
Large-scale testing (Phase 3)Study completedNCT00840801
What this trial is testing

Immunogenicity, Safety and Interchangeability of Two Tbe Vaccines Administered According to a Conventional Schedule in Children

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 302
Post-approval studies (Phase 4)Study completedNCT01106482
What this trial is testing

An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE

Who this might be right for
Tick Borne Encephalitis (TBE)
Novartis Vaccines 126
Post-approval studies (Phase 4)Study completedNCT02511535
What this trial is testing

TBE (Tick-borne Encephalitis) Vaccination in Allergic Patients

Who this might be right for
Vaccine Responsiveness in AllergyVaccine Responsiveness During Allergy De-sensitization Treatment
Medical University of Vienna 119
Not applicableUnknownNCT05607394
What this trial is testing

Prevalence of Tick-borne Encephalitis in the Pediatric Population Treated at the HUS and Characterization of Confirmed Pediatric Cases

Who this might be right for
Tick-borne Encephalitis
University Hospital, Strasbourg, France 500
Not applicableLooking for participantsNCT07358910
What this trial is testing

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Who this might be right for
DengueChikungunyaZika Virus Infection+55 more
Institut Pasteur du Cambodge 10,000
Post-approval studies (Phase 4)Study completedNCT00503529
What this trial is testing

TBE Antibody Persistence and Booster Vaccination Study in Adults (Follow-up to Study 223)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 314
Testing effectiveness (Phase 2)Ended earlyNCT01031537
What this trial is testing

Vaccine Study for Tick-Borne Encephalitis Virus (TBEV)

Who this might be right for
Tick-Borne EncephalitisEncephalitis, Tick-BorneTick-Borne Disease+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 69
Post-approval studies (Phase 4)Study completedNCT00452621
What this trial is testing

Evaluation of Long-Term Immunogenicity in Children and Adolescents Boosted With a New Pediatric TBE Vaccine After Five Years

Who this might be right for
Encephalitis, Tick-Borne
Novartis 235
Post-approval studies (Phase 4)Study completedNCT00804219
What this trial is testing

Humoral and Cellular Immunity of Low and High-responders After Tick-borne Encephalitis Vaccination

Who this might be right for
Tick-borne Encephalitis
Medical University of Vienna 67
Large-scale testing (Phase 3)Study completedNCT04648241
What this trial is testing

Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older

Who this might be right for
Tick-Borne Encephalitis
Pfizer 165
Not applicableStudy completedNCT00163618
What this trial is testing

Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Post-approval studies (Phase 4)Study completedNCT00161967
What this trial is testing

TBE Antibody Persistence and Booster Vaccination Study in Children and Adolescents (Follow-up to Study 209)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 375
Post-approval studies (Phase 4)Study completedNCT00894686
What this trial is testing

Tick-Borne Encephalitis (TBE) Seropersistence After First Booster and Response to a Second Booster in Children, Adolescents and Young Adults (Follow-Up to Study 700401)

Who this might be right for
Encephalitis, Tick-Borne
Pfizer 179
Load More Results